Article
Self-selection by genetically modified committed lymphocyte precursors reverses the phenotype of JAK3-deficient mice without myeloablation.
Human gene therapy - 20 Nov 2000
Bunting K D, Lu T, Kelly P F, Sorrentino B P
Abstract excerpt
Janus kinase 3 (JAK3) is an essential component of cytokine receptor signal transduction pathways required for normal lymphocyte development and function. JAK3 deficiency in both mice and humans results in severe combined immunodeficiency (SCID) and increased susceptibility to opportunistic infections. We have previously shown that JAK3 gene transfer into irradiated recipients could restore immune function....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
